The total return over the past 12 months is +37.49% vs. +16.94% for the S&P 500. So far it's up +10.10% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | +37.49% | +12.87% | +7.32% | N/A | N/A | N/A |
| Total Return CAGR | +37.49% | +12.87% | +7.32% | N/A | N/A | N/A |
| Revenue CAGR | N/A | +73.07% | +45.80% | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
IDEAYA Biosciences, Inc. (IDYA)
| Year | Start price | End price | IDYA Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $34.57 | $38.06 | +10.10% | +14.51% | (4.41%) |
| 2025 | $25.70 | $34.57 | +34.51% | +17.72% | +16.79% |
| 2024 | $35.58 | $25.70 | (27.77%) | +24.89% | (52.66%) |
| 2023 | $18.17 | $35.58 | +95.82% | +26.19% | +69.63% |
| 2022 | $23.64 | $18.17 | (23.14%) | (18.17%) | (4.97%) |
| 2021 | $14.00 | $23.64 | +68.86% | +28.74% | +40.12% |
| 2020 | $7.50 | $14.00 | +86.67% | +18.37% | +68.30% |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
